Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering Thomas ClozelCEO at OWKINSpeaker
Profile
Thomas is the CEO and Co-Founder at Owkin, leading medical research and business intelligence. He is a former Assistant Professor of Clinical Onco-Hematology at Hopital Henri Mondor in Paris. Thomas is also a former member of Ari Melnick’s lab at the Weill Cornell Medical College where he co-led several projects focused on prediction of resistance to chemotherapy in B-cell lymphoma.
Agenda Sessions
AI shaping therapeutics destiny: a more personalized understanding of biopharma and treatments
, 11:00View Session